Bactiguard Holding AB (publ) (STO:BACTI.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
18.50
+0.30 (1.65%)
At close: Apr 28, 2026

Bactiguard Holding AB Company Description

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas.

It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded.

The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures.

It operates in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally.

The company has licensed partnership with Becton, Dickinson & Company for urinary catheter bardex IC and lubrisil IC; Well Lead Medical for catheters and tubes; and Zimmer Biomet for orthopedic trauma implants.

The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Bactiguard Holding AB (publ)
Bactiguard Holding AB logo
Country Sweden
Founded 2005
Industry Medical Devices
Sector Healthcare
Employees 157
CEO Christine Lind

Contact Details

Address:
Vasagatan 11
Stockholm, 111 20
Sweden
Phone 46 84 40 58 80
Website bactiguard.com

Stock Details

Ticker Symbol BACTI.B
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0005878741
SIC Code 3842

Key Executives

Name Position
Christine Lind Chief Executive Officer
Patrick Fruergaard Bach Chief Financial Officer
Dr. Nathaniel Bachrach Ph.D. Chief Scientific Officer
Kajsa Bjorklund Executive Vice President of Research and Development
Mattias Thorsson Executive Vice President of Communications
Sophie Dahan Executive Vice President of Business Development and Alliance Management
Ian S. E. N. Christensen Senior Vice President of Wound Management
Alf Laurell Executive Vice President of Regulatory and Quality